- DKSH's expanded partnership with Grünenthal adds four pain therapies to eight APAC markets but remains a minor revenue contributor. - The company operates as Asia's outsourced sales-and-marketing ...
DKSH and Grünenthal ink new partnership agreement to accelerate access to innovative pain management solutions across eight markets in Asia-Pacific: Singapore Tuesday, September ...
SINGAPORE – EQS Newswire – Ngày 28 tháng 9 năm 2026 – DKSH – Đơn vị kinh doanh Chăm sóc sức khỏe, đối tác chiến lược và nhà cung cấp hàng đầu về Dịch vụ Mở rộng thị trường cho các công ty dược phẩm, t ...
Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthcare business partner and leading provider of Market Expansion Services for ...
The partnership will bring Qutenza®, Vimovo®, Palexia® and Zomig® to people living with pain in Asia-Pacific, spanning Hong ...
For more than 160 years, DKSH has been delivering growth for companies in Asia Pacific, Europe, and North America across its ...
Grünenthal has entered a new partnership with DKSH to expand access to four established pain medicines across Asia-Pacific.
The partnership will bring Qutenza, Vimovo, Palexiaand Zomig to people living with pain in Asia-Pacific, spanning Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand and ...
Im Rahmen dieser Partnerschaft für den asiatisch-pazifischen Raum - Hongkong, Indonesien, Malaysia, die Philippinen, Singapur, Taiwan, Thailand und Vietnam - soll Menschen, die von Schmerzen betroffen ...
Aachen (ots) - - Im Rahmen dieser Partnerschaft für den asiatisch-pazifischen Raum - Hongkong, Indonesien, Malaysia, die Philippinen, Singapur, Taiwan, Thailand und Vietnam ...
DKSH und Grünenthal haben eine neue regionale Partnerschaft für acht Märkte im asiatisch-pazifischen Raum vereinbart. Die Zusammenarbeit verbindet Grünenthals führende Position im Bereich ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results